University of Notre Dame du Lac’s United Therapeutics UTHR Stock Holding History

University of Notre Dame du Lac’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-21,784	Closed	-$2.56M	–	71
2019 Q1	$2.56M	Buy	21,784 +2,033	+10%	+$237K	0.57%	52
2018 Q4	$2.15M	Sell	19,751 -2,787	-12%	-$323K	0.52%	57
2018 Q3	$2.88M	Sell	22,538 -3,140	-12%	-$388K	0.54%	57
2018 Q2	$2.9M	Buy	25,678 +6,732	+36%	+$740K	0.56%	54
2018 Q1	$2.13M	Sell	18,946 -3,139	-14%	-$399K	0.4%	71
2017 Q4	$3.27M	Buy	22,085 +2,497	+13%	+$317K	0.68%	49
2017 Q3	$2.3M	Sell	19,588 -475	-2%	-$60.7K	0.64%	68
2017 Q2	$2.6M	Buy	20,063 +2,821	+16%	+$352K	0.77%	61
2017 Q1	$2.33M	Buy	+17,242	New	+$2.61M	0.58%	68

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

University of Notre Dame du Lac's UTHR Position: Q2 2019 in Review

University of Notre Dame du Lac sold out of United Therapeutics (UTHR) in Q2 2019, closing a stake of 21,784 shares — an estimated $2.56M sold.

University of Notre Dame du Lac first reported a position in UTHR in Q1 2017 and held it in 9 quarters. The position peaked at $3.27M in Q4 2017. 320 funds tracked by Wall St. Rank hold UTHR as of Q2 2019.

University of Notre Dame du Lac reported no remaining United Therapeutics position as of Q2 2019 after selling out during the quarter.
University of Notre Dame du Lac sold 21,784 United Therapeutics shares in Q2 2019, an estimated $2.56M.
University of Notre Dame du Lac first reported a position in United Therapeutics in Q1 2017 and held it in 9 quarters.
University of Notre Dame du Lac's United Therapeutics position peaked at $3.27M in Q4 2017.
320 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2019.

Based on University of Notre Dame du Lac's 13F filing for Q2 2019, filed 14 Aug 2019.